Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Ambria Capital

WebsiteLinkedIncbCrunchbase
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
  • Israel
  • USA
  • Canada
Investment stages
  • Seed
  • Series A
Industries
  • Real Estate
About
Ambria Capital, founded in 2018, is a venture Capital firm specializing in early stage investments in the healthcare and life sciences sectors. The firm supports companies that are developing innovative solutions in drug discovery, BioTech, and clinical services.
Min check size
$1M
Max check size
$20M
Fund size
NPS

Investment Thesis

Ambria Capital focuses on early stage investments in the healthcare and life sciences sectors, particularly in companies that are innovating in clinics, outpatient services, drug discovery, and BioTech.
Lead investor
Co Invest
Number of exits
Preferred contact method

Ambria Capital Contacts Information

Primary contact

Secondary contact

Portfolio

Stella (Clinics/Outpatient Services)

HealingMaps

Tyson 2.0

Clairvoyant (Drug Discovery)

Wonder Sciences

CityRow

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp